A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC

Clinical trial NCT02852083 · UNKNOWN

Trial details

NCT number: NCT02852083
Sponsor: University Hospital Regensburg
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Lung Cancer Non-Squamous Cell Lung Cancer Non-Small Cell Lung Cancer

Start date: 2016-01-01
Primary completion: 2019-07-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.